Medical/Pharmaceuticals

Bioscience Animal Health Public Company Limited Accorded the International Innovation Awards 2021 for Angentex® COVID-19 qPCR Detection Kit

SINGAPORE, Dec. 17, 2021 /PRNewswire/ -- Enterprise Asia is pleased to honor 52 award recipients at the International Innovation Awards 2021. Spearheading the Innovation Revolution, the International Innovation Awards which aims to create an innovation ecosystem for enterprises is held annually t...

2021-12-17 18:24 2533

Study on Anti-aging with TCM Strides Forward

SHIJIAZHUANG, China, Dec. 17, 2021 /PRNewswire/ -- The opinions of experts on "Study on Anti-aging with Bazi Bushen Capsules Guided by Qi Collateral Theory" were released inShijiazhuang, Hebei on December 15. According to the opinions, the preliminary research of the project has created the theo...

2021-12-17 17:06 3669

Lipidor expands clinical program, announces investment in new drug development project against acne vulgaris

STOCKHOLM, Dec. 17, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North: LIPI) today announces that it has initiated a preclinical program for a new drug candidate, AKP-08, focused on acne vulgaris (acne). The market for acne medicines amounts to about35 billion SEK per year, which togethe...

2021-12-17 16:10 2889

"academist" and Sysmex R&D Center Europe to Begin Collaborating in Exploring and Nurturing "Research Seeds" in Europe

TOKYO, Dec. 17, 2021 /PRNewswire/ -- academist, Inc., which operates Japan's first academic crowdfunding platform (https://academist-cf.com/?lang=en ), and Sysmex R&D Center Europe GmbH (hereinafter "Sysmex R&D Center Europe,"https://www.sysmex-rdce.com/

2021-12-17 14:00 2512

Transcenta Announces the Appointment of Daniel Weng as CFO

SUZHOU, China, Dec. 17, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of Da...

2021-12-17 08:30 4867

Global Cord Blood Corporation Announces Rejection of Alternate Ocean Proposal

HONG KONG, Dec. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its Board of Directors (the "...

2021-12-17 05:16 4462

Huawei supports Thailand launch 5G Smart Hospital

BANGKOK, Dec. 16, 2021 /PRNewswire/ -- Thailand Office of The National Broadcasting and Telecommunications Commission (NBTC), Siriraj Hospital, and Huawei Technologies (Thailand) Co., Ltd. on Thursday jointly launched the "Siriraj World Class 5G Smart Hospital."

2021-12-16 19:03 3352

SenseTime Partners with Macau's Kiang Wu Hospital to Advance Smart Health Application with AI

MACAU, Dec. 16, 2021 /PRNewswire/ -- SenseTime, a leading global artificial intelligence (AI) software company, has formed a strategic partnership with Kiang Wu Hospital, one of the largest and oldest hospitals inMacau to advance smart health application and research with AI.

2021-12-16 18:01 3532

BINUS SCHOOL Simprug Announces Students' Participation in an International Scientific Publication about COVID-19

JAKARTA, Indonesia, Dec. 16, 2021 /PRNewswire/ -- BINUS SCHOOL Simprug, an International Baccalaureate (IB)World School in Indonesia, announces that 15 of their high school students have participated in the creation of a scientific journal titledVoice Processing for COVID-19 Scanning and Progn...

2021-12-16 17:02 3395

SenseTime Partners with Macau's Kiang Wu Hospital to Advance Smart Health Application with AI

MACAU, Dec. 16, 2021 /PRNewswire/ -- SenseTime, a leading global artificial intelligence (AI) software company, has formed a strategic partnership with Kiang Wu Hospital, one of the largest and oldest hospitals inMacau to advance smart health application and research with AI.

2021-12-16 16:58 4722

Antengene and XtalPi Announce AI-Driven R&D Collaboration

SHANGHAI and HONG KONG, Dec. 16, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life...

2021-12-16 16:30 4575

BioWorld by Clarivate Identifies the Top Six Global Biopharmaceutical Stories and Trends of 2021

Advances in Alzheimer's, innovation in DNA vaccines, increased regulatory collaboration and the evolving impact of Artificial Intelligence, join Covid-19 as key stories and trends of 2021 LONDON, Dec. 16, 2021 /PRNewswire/ -- BioWorld published by Clarivate Plc  (NYSE:CLVT), a global leader in pr...

2021-12-16 16:14 2954

Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study

Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors LAUSANNE, Switzerland, Dec. 16, 2021 /PRNewswire/ -- Debiopharm ( www.debiopharm.com ), a Swiss biopharmaceutica...

2021-12-16 16:00 2697

PHASE 3 TRIAL OF SHR8058 EYE DROPS (PERFLUOROHEXYLOCTANE) CONDUCTED BY JIANGSU HENGRUI PHARMACEUTICALS IN THE PEOPLE'S REPUBLIC OF CHINA SHOWS STATISTICALLY SIGNIFICANT TOPLINE RESULTS

HEIDELBERG, Germany, and CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today provided a development update on the phase 3 trial of SHR8058 eye drops ...

2021-12-16 15:00 2825

French Neurosurgeon and Physicist Dr. Alim Louis Benabid, Recipient of 42nd Honda Prize, Honored at Online Award Ceremony

TOKYO, Dec. 16, 2021 /PRNewswire/ -- The Honda Foundation, based in Tokyo, is pleased to announce that the 42nd Honda Prize Award Ceremony was held on Wednesday, November 17, 2021, and awarded this year's prize to Dr. Alim Louis Benabid, emeritus professor at the Joseph Fourier University and chai...

2021-12-16 15:00 2016

LifeTech and Medtronic Further Strategic Collaboration to Open New Chapter of Domestically-Made MRI-Conditional Pacemakers

SHENZHEN, China, Dec. 16, 2021 /PRNewswire/ -- LifeTech Scientific Corporation (LifeTech, 01302.HK) announced that it has extended its agreements with Medtronic to further the strategic collaboration on the "HeartTone™ domestic pacemaker project" and to start the collaboration on domestically-mad...

2021-12-16 12:41 5215

Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine

-- Takeda submits application for TAK-019/NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for NDA, toJapan's Ministry of Health, Labour and Welfare (MHLW) -- Interim data from Phase 1/2 trial in Japan demonstrate robust immune response and favorable tolerability with no serious a...

2021-12-16 12:03 3455

The Clinician begins rollout of patient-reported outcome and experience measures for the Singapore public healthcare system

SINGAPORE, Dec. 16, 2021 /PRNewswire/ -- The Clinician , a global digital health leader, has partnered with Singapore's HealthTech agency, Integrated Health Information Systems (IHiS), to launch an electronic patient-reported outcome and experience measures (PROMs and ...

2021-12-16 10:20 4765

Prenetics Launches Circle Healthpod At Hong Kong International Airport, Providing Travellers With Rapid COVID-19 PCR Quality Results In Less Than 60 Minutes

* Results Available In the Form of Digital Health Passport, SMS and Email * HealthPod Results Accepted by 13 Countries as Valid Pre-Departure COVID-19 Test:USA, Canada, UK, Spain, Germany, Italy, Netherlands, Sweden, Luxembourg, New Zealand, South Korea and more * Circle HealthPod, with Te...

2021-12-16 09:00 4254

Everest Medicines announces FDA grants our Partner Calliditas Therapeutics Accelerated Approval of TARPEYO™ (budesonide) to Reduce Proteinuria in IgA Nephropathy

* TARPEYO (budesonide) delayed release capsules is the first and only treatment indicated to reduce proteinuria in adults withprimary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5g/g1 * TARPEYO (developed un...

2021-12-16 08:49 5238
1 ... 360361362363364365366 ... 380